9069 Results

Journal Article

Dedicated isotropic 3-D T1 SPACE sequence imaging for radiosurgery planning improves brain metastases detection and reduces the risk of intracranial relapse

Authors: Tugce Kutuk, Kevin J. Abrams, Martin C. Tom, Muni Rubens, Haley Appel, Charif Sidani, Matthew D. Hall, Ranjini Tolakanahalli, D. Jay J. Wieczorek, Alonso N. Gutierrez, Michael W. McDermott, Manmeet S. Ahluwalia, Minesh P. Mehta, Rupesh Kotecha

Journal Article

Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy

Authors: Max Peters, Jochem R.N. van der Voort van Zyp, Marinus A. Moerland, Carel J. Hoekstra, Sandrine van de Pol, Hendrik Westendorp, Metha Maenhout, Rob Kattevilder, Helena M. Verkooijen, Peter S.N. van Rossum, Hashim U. Ahmed, Taimur T. Shah, Mark Emberton, Marco van Vulpen

Congress Abstract

Can we ignore rotational errors in the positioning of patients with high-risk prostate cancer?

Authors: Poncyljusz|, Maria(1)*[mjaponc@gmail.com];Piziorska|, Maria(1);Czyzew|, Beata(1);Piotrkowicz|, Norbert(1);
(1)The Central Clinical Hospital of the Ministry of The Interior and Administration in Warsaw, The Radiotherapy Center, Warsaw, Poland;
Show Affiliations

Congress Abstract

Set-up accuracy of BrainLab immobilization mask for intracranial stereotactic radiotherapy

Authors: Di Carlo|, Clelia(1)*[clelia.dicarlo@ospedaliriuniti.marche.it];Valenti|, Marco(2);Costantini|, Sara(1);Cucciarelli |, Francesca(1);Fenu|, Francesco(1);Vicenzi|, Lisa(1);Di Biase|, Saide(1);Maggi|, Stefania(2);Mantello|, Giovanna(1);
(1)Ospedali Riuniti Ancona, Radiotherapy Department, Ancona, Italy;(2)Ospedali Riuniti Ancona, Medical Physics, Ancona, Italy;
Show Affiliations

Congress Abstract

Integrated radiogenomics analyses for outcome prognosis in patients with locally advanced HNSCC

Authors:

Asier Rabasco1,2, Alex Zwanenburg1,3,4, Annett Linge1,3,4,5, Fabian Lohaus1,3,4,5, Marianne Grosser6, Gustavo Baretton3,4,6,7, Goda Kalinauskaite8,9, Inge Tinhofer8,9, Nika Guberina10,11, Maja Guberina10,11, Panagiotis Balermpas12,13, Jens von der Grün12,13, Ute Ganswindt14,15,16,17, Claus Belka14,15,16, Jan C. Peecken14,18,19, Stephanie E. Combs14,18,19, Simon Böcke20,21, Daniel Zips20,21, Michael Baumann1,2,3,4,5,22, Esther G.C. Troost1,2,3,4,5, Mechthild Krause1,2,3,4,5, Steffen Löck1,3,5

1OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; 2Institute of Radiooncology – OncoRay, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; 3German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany; 4National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany; 5Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus- Technische Universität Dresden, Dresden, Germany; 6Institute of Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 7Tumour- and Normal Tissue Bank, University Cancer Centre (UCC), University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 8German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany; 9Department of Radiooncology and Radiotherapy, Charité University Medicine Berlin, Berlin, Germany; 10German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Partner Site Essen, Essen, Germany; 11Department of Radiotherapy, University Hospital Essen, Medical Faculty, University of Duisburg-Essen, Essen, Germany; 12German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany; 13Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany; 14German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany; 15Department of Radiation Oncology, Ludwig-Maximilians-Universität, Munich, Germany; 16Clinical Cooperation Group, Personalized Radiotherapy in Head and Neck Cancer, Helmholtz Zentrum Munich, Munich, Germany; 17Department of Radiation Oncology, Medical University of Innsbruck, innsbruck, Austria; 18Department of Radiation Oncology, Technische Universität München, Munich, Germany; 19Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Neuherberg, Germany; 20German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany; 21Department of Radiation Oncology, Faculty of Medicine and University Hospital Tübingen, Eberhard Karls Universität Tübingen, Tübingen, Germany; 22German Cancer Research Center (DKFZ), Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany

Show Affiliations

Congress Abstract

Rectal volumes comparison in prostate cancer radiotherapy treated before and after noon in 1140 CBCT

Authors: Umbarkar|, Prakash(1)*[umbarkarprakash@gmail.com];harjani hinduja|, r(1);deshpande|, s(1);naidu|, s(1);jadhav|, o(1);ullagaddi|, s(1);shinde|, s(1);parmar|, n(1);jejurkar|, a(1);kamble|, p(1);anand|, v(1);bajpai|, r(1);kabre|, r(1);alurkar|, p(1);mistari|, w(1);kannan|, v(1);
(1)P D Hinduja Hospital, Radiation oncology, Mumbai, India;
Show Affiliations

Congress Abstract

Upfront radiotherapy is mandatory in patients with brain mets even in the era of immunotherapy

Authors: Andratschke|, Nicolaus(1)*[Nicolaus.Andratschke@usz.ch];
(1)University Hospital Zürich, Department of Radiation Oncology, Zurich, Switzerland;
Show Affiliations
*:*